Benjamin Edwards Inc Abbott Laboratories Transaction History

Benjamin Edwards Inc

$8.36 Billion
Q3 2025

A detailed history of Benjamin Edwards Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Benjamin Edwards Inc holds 346,766 shares of ABT stock, worth $45.1 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

346,766

Previous 334,083 3.8%

Holding current value

$45.1 Million

Previous $45.4 Million 2.22%

% of portfolio

0.56%

Previous 0.61%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	BUY	$120.51 - $136.62 $1.53 Million - $1.73 Million	12,683 Added 3.8%	346,766 $46.4 Million
Q2 2025 Aug 14, 2025	BUY	$123.95 - $138.08 $1.03 Million - $1.15 Million	8,326 Added 2.56%	334,083 $45.4 Million
Q1 2025 May 12, 2025	SELL	$111.1 - $140.22 $2.51 Million - $3.17 Million	-22,575 Reduced 6.48%	325,757 $43.2 Million
Q4 2024 Feb 14, 2025	BUY	$111.93 - $119.39 $1.32 Million - $1.41 Million	11,795 Added 3.5%	348,332 $39.4 Million
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $28.8 Million - $34 Million	287,620 Added 587.98%	336,537 $38.4 Million

Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $489,144 - $546,008	-4,856 Reduced 9.03%	48,917 $5.08 Million
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $315,855 - $348,848	2,884 Added 5.67%	53,773 $6.11 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $167,392 - $204,902	1,856 Added 3.79%	50,889 $5.6 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $478,605 - $574,246	5,010 Added 11.38%	49,033 $4.75 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $488,682 - $544,494	4,849 Added 12.38%	44,023 $4.8 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $363,321 - $427,651	3,751 Added 10.59%	39,174 $3.97 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $170,917 - $200,512	1,798 Added 5.35%	35,423 $3.89 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $216,355 - $250,499	2,236 Added 7.12%	33,625 $3.25 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $318,152 - $384,544	3,117 Added 11.03%	31,389 $3.41 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $751,163 - $915,995	6,588 Added 30.38%	28,272 $3.35 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $1.48 Million - $1.81 Million	12,772 Added 143.31%	21,684 $3.05 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $48,997 - $54,205	420 Added 4.95%	8,912 $1.05 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $2,750 - $3,237	26 Added 0.31%	8,492 $984,000
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $45,277 - $53,343	416 Added 5.17%	8,466 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $747,075 - $814,098	7,115 Added 760.96%	8,050 $881,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $56,908 - $69,111	621 Added 197.77%	935 $102,000
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $7,161 - $10,472	114 Added 57.0%	314 $25,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $13,244 - $16,012	200 New	200 $16,000

Others Institutions Holding ABT

# of Institutions

3,651

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Abbott Laboratories Transaction History